CG Oncology, Inc. (CGON)
(Delayed Data from NSDQ)
$36.49 USD
+1.12 (3.17%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $36.48 -0.01 (-0.03%) 5:32 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for CG Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -48.61 | -35.44 | NA | NA | NA |
Depreciation/Amortization & Depletion | -2.82 | 0.06 | NA | NA | NA |
Net Change from Assets/Liabilities | 3.44 | 4.44 | NA | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | NA | NA |
Other Operating Activities | 2.31 | 1.14 | NA | NA | NA |
Net Cash From Operating Activities | -45.68 | -29.80 | NA | NA | NA |
Property & Equipment | 0.00 | -0.01 | NA | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | NA | NA |
Investments | -121.20 | -55.34 | NA | NA | NA |
Other Investing Activities | 0.00 | 0.00 | NA | NA | NA |
Net Cash from Investing Activities | -121.20 | -55.35 | NA | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 106.71 | 119.69 | NA | NA | NA |
Issuance (Repayment) of Debt | -16.29 | 0.00 | NA | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | NA | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | NA | NA |
Other Financing Activities | -3.42 | 0.00 | NA | NA | NA |
Net Cash from Financing Activities | 87.00 | 119.69 | NA | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | NA | NA | NA |
Net Change In Cash & Equivalents | -79.88 | 34.54 | NA | NA | NA |
Cash at Beginning of Period | 88.14 | 53.61 | NA | NA | NA |
Cash at End of Period | 8.27 | 88.14 | NA | NA | NA |
Diluted Net EPS | -15.65 | NA | NA | NA | NA |
Fiscal Year End for CG Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -35.84 | -16.93 | -48.61 | NA | -20.28 |
Depreciation/Amortization & Depletion | -4.65 | -2.20 | -2.82 | NA | -0.23 |
Net Change from Assets/Liabilities | -5.39 | -8.40 | 3.44 | NA | 0.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Other Operating Activities | 3.75 | 1.51 | 2.31 | NA | 1.08 |
Net Cash From Operating Activities | -42.13 | -26.01 | -45.68 | NA | -18.77 |
Property & Equipment | -0.03 | -0.01 | 0.00 | NA | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Investments | -343.65 | -307.43 | -121.20 | NA | 24.66 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Net Cash from Investing Activities | -343.67 | -307.44 | -121.20 | NA | 24.66 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 406.49 | 406.41 | 106.71 | NA | 0.23 |
Issuance (Repayment) of Debt | -0.37 | -0.37 | -16.29 | NA | -16.22 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Other Financing Activities | -3.42 | -3.39 | -3.42 | NA | 0.00 |
Net Cash from Financing Activities | 402.70 | 402.66 | 87.00 | NA | -15.99 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Net Change In Cash & Equivalents | 16.89 | 69.20 | -79.88 | NA | -10.10 |
Cash at Beginning of Period | 8.27 | 8.27 | 88.14 | NA | 88.14 |
Cash at End of Period | 25.16 | 77.47 | 8.27 | NA | 78.04 |
Diluted Net EPS | -0.28 | -0.36 | NA | NA | NA |